Viewing Study NCT03442569


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2025-12-25 @ 8:32 PM
Study NCT ID: NCT03442569
Status: COMPLETED
Last Update Posted: 2025-07-01
First Post: 2018-02-14
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization: